The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 1
Abstract
Cervical cancer is the third most prevalent cancer in women globally, with 529,000 diagnosis and 275,000 deaths each year. It is especially prevalent in developing countries where approximately 85% of cases arise due to the lack of cervical cancer prevention and control programs. In developed countries, where women have access to resources capable of detecting and treating precancerous lesions, the number of cases is reduced by approximately 80%.1 Cervical cancer can be characterised, depending on how far it has spread, from stage 0 (precancerous), also called Cervical Intraepithelial Neoplasia (CIN), where abnormal cells are found in the innermost lining of the cervix and have the potential to become cancerous, through to stage 4, where the cancer has spread to the bladder, rectum or other parts of the body, such as the lungs. In developed countries, there are currently two methods used to prevent cervical cancer from developing to an advanced stage: (1) the distribution of HPV vaccines that are mainly directed against HPV types 16 and 182 and (2) screening methods, such as Papanicolaou test (Pap smear), which involves the collection of exfoliated cells from the cervix, which are then examined for cellular abnormalities. This enables identification of CIN before they begin to develop into cervical cancer.
Authors and Affiliations
Christopher McConville
Keywords
Related Articles
- EP ID EP553476
- DOI 10.17140/GOROJ-2-106
- Views 186
- Downloads 0
Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum Disorder
Background: Cerebellar developmental abnormalities in Fetal Alcohol Spectrum Disorder (FASD) are linked to impairments in insulin signaling. However, co-morbid alcohol and tobacco abuses during pregnancy are common. Sinc...
Case Report of Unusual Stromal Luteinization in High-Grade Papillary Serous Carcinoma of the Ovary
Stromal luteinization has been reported to be associated with benign and malignant epithelial ovarian tumors, predominantly mucinous and often endometrioid ovarian neoplasm. We report here an unusual case of marked ovari...
Ovarian Cystectomy for Huge Mature Cystic Teratoma Developed in Less than Five Years: A Case Report
Cystic ovarian teratomas, also known as dermoid cysts, are the most common benign ovarian germ cell tumors. They typically occur during reproductive age. Due to the readable accessibility to ultrasonography, the finding...
Analyzing Pregnancy Costs with Finite Mixture Models: An Opportunity to More Adequately Accommodate the Presenceof Patient Data Heterogeneity
The choice of a model in the analysis of patient health care costs and utilization is critical for a clear understanding of the behavior and estimation of quantities like incremental costs or cost-effectiveness. In study...
Association of Pseudo-Meigs’ Syndrome with Struma Ovarii and High CA125 Mimicking Ovarian Malignancy
Pseudo-Meigs’ syndrome (PMS) is a rare condition in which a non-fibroma ovarian tumor, pleural effusion, and ascites coexist, and in which removal of the tumor resolves the condition. We present here a patient with strum...